Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2023-03-29 | 2023-03-29 |
| Drug Identification Number | 02239200 | 02239200 |
| Brand name | HIBERIX | HIBERIX |
| Common or Proper name | Haemophilus influenzae type b (Hib) conjugate vaccine | Haemophilus influenzae type b (Hib) conjugate vaccine |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE |
| Strength(s) | 10MCG | 10MCG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | All pack sizes / Tous les formats | All pack sizes / Tous les formats |
| ATC code | J07AG | J07AG |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2023-03-24 | 2023-03-24 |
| Remaining supply date | 2023-06-30 | 2023-06-30 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |